Article
Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness.
British journal of cancer - 30 Apr 2013
de Bock G H, Vermeulen K M, Jansen L, Oosterwijk J C, Siesling S, Dorrius M D, Feenstra T, Houssami N, Greuter M J W
Abstract excerpt
BACKGROUND: There is no consensus on the most effective strategy (mammography or magnetic resonance imaging (MRI)) for screening women with BRCA1 or BRCA2 mutations. The effectiveness and cost-effectiveness of the Dutch, UK and US screening strategies, which involve mammography and MRI at different ages and intervals were evaluated in high-risk women with BRCA1 or BRCA2 mutations. METHODS: Into a validated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.